NCT00004061View on ClinicalTrials.gov

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

May 31, 2003

Study Completion Date

December 31, 2009

Conditions

LeukemiaLymphomaOral Complications

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

palifermin

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

ifosfamide

PROCEDURE

peripheral blood stem cell transplantation

PROCEDURE

quality-of-life assessment

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004061 - Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | Biotech Hunter | Biotech Hunter